ROLE OF ALPHA-2-ADRENOCEPTORS AND IMIDAZOLINE-BINDING SITES IN THE CONTROL OF INSULIN-SECRETION

被引:55
作者
CHAN, SLF
机构
[1] Cellular Pharmacology Group, Department of Biological Sciences, Keele University, Keele
关键词
ALPHA-2-ADRENOCEPTORS; ATP-SENSITIVE K+ CHANNELS; EFAROXAN; IMIDAZOLINE; INSULIN;
D O I
10.1042/cs0850671
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
[No abstract available]
引用
收藏
页码:671 / 677
页数:7
相关论文
共 85 条
[1]   EFFECTS OF ALPHA-1-ADRENOCEPTOR, ALPHA-2-ADRENOCEPTOR AND BETA-ADRENOCEPTOR BLOCKERS ON INSULIN-SECRETION IN THE RAT [J].
AHREN, B ;
LUNDQUIST, I ;
JARHULT, J .
ACTA ENDOCRINOLOGICA, 1984, 105 (01) :78-82
[2]   EFFECTS OF ALPHA-ADRENOCEPTOR BLOCKADE BY PHENTOLAMINE ON BASAL AND STIMULATED INSULIN-SECRETION IN THE MOUSE [J].
AHREN, B ;
LUNDQUIST, I .
ACTA PHYSIOLOGICA SCANDINAVICA, 1985, 125 (02) :211-217
[3]   SL-84.0418 - A NEW ALPHA-2 ANTAGONIST WITH ANTI-HYPERGLYCEMIC PROPERTIES [J].
ANGEL, I ;
SCHOEMAKER, H ;
DUVAL, N ;
OBLIN, A ;
SEVRIN, M ;
LANGER, SZ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (03) :990-991
[4]  
ATLAS D, 1984, EUR J BIOCHEM, V144, P287, DOI 10.1111/j.1432-1033.1984.tb08462.x
[5]  
ATLAS D, 1987, Journal of Cardiovascular Pharmacology, V10, pS122, DOI 10.1097/00005344-198710012-00019
[6]  
ATLAS D, 1984, FEBS LETT, V170, P387, DOI 10.1016/0014-5793(84)81350-2
[7]  
BEARD JC, 1982, DIABETES, V31, P802, DOI 10.2337/diab.31.9.802
[8]   COMPARISON OF THE EFFECTS OF EFAROXAN AND GLIBENCLAMIDE ON PLASMA-GLUCOSE AND INSULIN LEVELS IN RATS [J].
BERRIDGE, TL ;
DOXEY, JC ;
ROACH, AG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 213 (02) :213-218
[9]   SELECTIVITY PROFILE OF THE ALPHA-2-ADRENOCEPTOR ANTAGONIST EFAROXAN IN RELATION TO PLASMA-GLUCOSE AND INSULIN LEVELS IN THE RAT [J].
BERRIDGE, TL ;
DOXEY, JC ;
ROACH, AG ;
SMITH, CFC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 213 (02) :205-212
[10]   EVIDENCE FOR A DIRECT STIMULATORY EFFECT OF CIBENZOLINE ON INSULIN-SECRETION IN RATS [J].
BERTRAND, G ;
GROSS, R ;
PETIT, P ;
LOUBATIERESMARIANI, MM ;
RIBES, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 214 (2-3) :159-163